These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vasoactive intestinal peptide (VIP): a new neuroendocrine marker of clinical progression in chronic heart failure? Lucia P; Caiola S; Coppola A; Manetti LL; Maroccia E; Buongiorno AM; De Martinis C Clin Endocrinol (Oxf); 2003 Dec; 59(6):723-7. PubMed ID: 14974913 [TBL] [Abstract][Full Text] [Related]
3. [The physiopathological role and prognostic value of the vasoactive intestinal peptide in acute myocardial infarct]. Lucia P; Caiola S; Coppola A; Maroccia E; Belli M; Colliardo A; Borelli LG; De Martinis C; Buongiorno A Cardiologia; 1995 Aug; 40(8):579-84. PubMed ID: 8536284 [TBL] [Abstract][Full Text] [Related]
5. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients. Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505 [TBL] [Abstract][Full Text] [Related]
6. Plasma concentration of atrial natriuretic peptide is related to the duration of atrial fibrillation in patients with advanced heart failure. Wozakowska-Kapłon B; Opolski G; Janion M; Kosior D Kardiol Pol; 2004 Dec; 61(12):513-21; discussion 522. PubMed ID: 15815752 [TBL] [Abstract][Full Text] [Related]
7. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure. Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067 [TBL] [Abstract][Full Text] [Related]
8. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases. Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774 [TBL] [Abstract][Full Text] [Related]
9. Release of vasoactive intestinal peptide by intraduodenal infusion of HCl or fat and intramuscular injection of neostigmine in man. Shinomura Y; Himeno S; Kurokawa M; Takahashi S; Kuroshima T; Okuno M; Kanayama S; Tsuji K; Higashimoto Y; Tarui S Hepatogastroenterology; 1985 Jun; 32(3):129-32. PubMed ID: 4018706 [TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine activation in acute myocardial infarction: state of the art and preliminary results on intestinal vasoactive peptide]. Caiola S; Lucia P; Coppola A; Maroccia E; Belli M; Ricciardi G; Borelli LG; Colliardo A; De Martinis C; Buongiorno AM Ann Ist Super Sanita; 1996; 32(3):339-43. PubMed ID: 9103159 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up. Sargento L; Brito D; Matias JS; Madeira H Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581 [TBL] [Abstract][Full Text] [Related]
12. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure]. Song HM; Zhang J; Deng B; Luo M Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction. Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963 [TBL] [Abstract][Full Text] [Related]
15. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies. Randa Abdel Kader M; Grace BD; Badawi NE Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350 [TBL] [Abstract][Full Text] [Related]
16. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Bellamy JL; Cady RK; Durham PL Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148 [TBL] [Abstract][Full Text] [Related]
18. Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure. Alehagen U; Dahlström U Int J Cardiol; 2009 Apr; 133(2):233-40. PubMed ID: 18407361 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure. Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581 [TBL] [Abstract][Full Text] [Related]
20. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern. Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]